Achieving Faster Recanalization Times by IA Thrombolysis in Acute Ischemic Stroke: Where Should We Direct Our Efforts?

Faster recanalization correlates with better outcomes in acute ischemic stroke. We analyzed times from arrival in ER to end of treatment in patients undergoing endovascular treatment for acute ischemic stroke at our institution. We retrospectively studied patients who underwent IA procedures for stroke from 2005 to 2009 noting the times of arrival to ER, CT scan, arrival to DSA, arterial puncture and recanalization from our endovascular database. A subgroup analysis was performed based on administration of GA, use of mechanical devices and whether the procedure was performed during regular hours or after hours. Of 101 patients, 53 were male, with a median age of 66 years (range 18–87). There were 81 anterior circulation strokes. Median ER to CT time was 22 min (2–1025), CT to DSA arrival time 80 min (range 4–990), DSA arrival to puncture time 24 min (range 0–75) and puncture to recanalization time 84 min (range 11–206). 23.3% of patients had an ER to CT time interval of > 60 min and 71.3 % had a CT to DSA time interval of > 60 min contributing to significant in-hospital delays. For subgroup analysis the Mann-Whitney test was used. No significant differences in CT to DSA arrival (p=0.8), DSA arrival to puncture (p=0.1) and puncture to recanalization (p=0.59) times were noted between patients with and without GA. No significant difference was noted in puncture to recanalization times with or without device (p=0.78). 39 cases were done during regular (R) hours and 62 after (A) hours. Median ER to CT time (R=18 min, A = 27 min, p 0.02), CT to DSA arrival time (R=64 min, A=90 min, p 0.004) and DSA arrival to puncture time (R=18 min, A=25 min, p 0.003) was significantly higher after hours. ER to CT and CT to DSA arrival times in patients undergoing endovascular stroke therapy show wide variability and therefore, considerable scope for reduction. Time differences during regular and after hours should serve as a reminder to make efforts to reduce overall ischemic times in spite of staffing patterns and resource availability.

[1]  C. Cannon,et al.  Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance. , 2009, The American journal of cardiology.

[2]  T. Struffert,et al.  Penumbra Stroke System as an “add-on” for the treatment of large vessel occlusive disease following thrombolysis: first results , 2009, European Radiology.

[3]  E. Antman.  Time is muscle: translation into practice. , 2008, Journal of the American College of Cardiology.

[4]  Harlan M Krumholz,et al.  Time to treatment in primary percutaneous coronary intervention. , 2007, The New England journal of medicine.

[5]  B. Baxter,et al.  The merci retrieval system for acute stroke , 2007, Neurocritical care.

[6]  P. Vespa,et al.  Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. , 2006, AJNR. American journal of neuroradiology.

[7]  Harlan M Krumholz,et al.  Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. , 2006, Journal of the American College of Cardiology.

[8]  Jane C Khoury,et al.  Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I , 2005, Stroke.

[9]  Ims Study Investigators.  Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke: The Interventional Management of Stroke Study , 2004, Stroke.

[10]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[11]  P. Akins,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[12]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[13]  W. Hacke,et al.  Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI , 1999, The Lancet.

[14]  J. Garcìa,et al.  Hemorrhagic Transformation in Focal Cerebral Ischemia: Influence of Time to Artery Reopening and Tissue Plasminogen Activator , 1999, Pharmacotherapy.

[15]  P. Wester,et al.  Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study.Seek- Medical-Attention-in-Time Study Group. , 1999, Stroke.

[16]  K. Muir,et al.  Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.

[17]  M. Kaste,et al.  The ECASS 3-Hour Cohort , 1998, Cerebrovascular Diseases.

[18]  R. Higashida,et al.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.

[19]  M. Kaste,et al.  The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. , 1998, Cerebrovascular diseases.

[20]  L. Wilkins.  Practice Advisory , 1996, Neurology.

[21]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[22]  M. Kaste,et al.  The European Cooperative Acute Stroke Study (ECASS) , 1993 .